Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2020-12-14 22:07 Tx date 2020-11-30 |
$PAS
Pascal Biosciences Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$62,170
+310,850 vol $0.20 each |
980,849 | |
Filed 2020-03-06 10:20 Tx date 2020-03-05 |
$SOC
Sonora Gold & Silver Corp. |
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
600,000 | |
Filed 2020-03-06 10:19 Tx date 2016-04-28 |
$SOC
Sonora Gold & Silver Corp. |
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-08-07 Tx date 2018-08-03 |
$PAS
Pascal Biosciences Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
572,500 | |
Filed 2016-05-03 Tx date 2016-04-28 |
$SOC
Sonora Gold & Silver Corp. |
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,964,109 | ||
Filed 2016-05-03 Tx date 2016-04-28 |
$SOC
Sonora Gold & Silver Corp. |
BIERTUMPEL, JENS
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-04-22 Tx date 2016-04-22 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+23,333 vol |
669,999 | |
Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
422,500 | |
Filed 2016-03-04 Tx date 2016-03-01 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+36,000 vol |
110,000 | |
Filed 2016-02-16 Tx date 2016-02-12 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+4,000 vol |
74,000 | |
Filed 2016-02-05 Tx date 2016-02-02 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
70,000 | |
Filed 2016-02-01 Tx date 2016-01-27 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,000 vol |
646,666 | |
Filed 2016-01-26 Tx date 2016-01-22 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
60,000 | |
Filed 2015-11-30 Tx date 2015-11-19 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+50,000 vol |
50,000 | |
Filed 2015-11-30 Tx date 2015-06-30 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-10-05 Tx date 2015-10-02 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+50,000 vol |
641,666 | |
Filed 2015-08-11 Tx date 2015-08-04 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$124,000
+400,000 vol $0.31 each |
400,000 | |
Filed 2015-07-10 Tx date 2015-06-30 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-10 Tx date 2015-06-30 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
591,666 |